Here are seven things to know about the company’s Q1 results:
1. Surgalign’s first quarter revenue reached $16.7 million, as compared with $20.6 million in the first quarter of last year and $20.6 million last quarter.
2. The revenue decrease was due in part to a reduction in product offerings related to ongoing restructuring efforts.
3. The company saw a gross margin of 63.7 percent, down 520 basis points from a year ago.
4. Operating expenses were up $1.3 million to $24.4 million for the quarter.
5. The company saw an operating loss of $1.1 million, compared with $8.9 million a year ago.
6. Adjusted earnings saw a loss of $10.8 million.
7. During the quarter Surgalign’s Holo artificial intelligence spine imaging tool expanded into two new sites and one new state.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
